Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects

PHASE3TerminatedINTERVENTIONAL

Enrollment

406

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions

HIV Infection

Interventions

DRUG

GW873140

Trial Locations (5)

GSK Investigational Site, Berlin

GSK Investigational Site, Hanover

GSK Investigational Site, Hanover

GSK Investigational Site, Düsseldorf

GSK Investigational Site, Frankfurt am Main